Side effects and indications
Whenever possible, frequency information about the side effects was extracted from the labels. Aggregated frequency information for the drug and, if available, placebo is shown. To the right, you can click on shaded boxes to be taken to mentions of the side effect on the label. (In some cases, the side effect cannot be highlighted due to conversion problems.)
Information about indications was extracted from the indications and usage sections of the labels.
Show MedDRA Preferred Terms
|
Information
More information: STITCH, PubChem and possibly Wikipedia or Medpedia
ATC Code:
A04AA04
Legend
Color scheme:
standard – alternative
|
100%
|
|
|
|
75%
|
|
|
|
50%
|
|
|
|
10%
|
|
|
|
frequent (1% to 100%)
|
|
|
|
infrequent (0.1% to 1%)
|
|
|
|
rare (<0.1%)
|
|
|
|
postmarketing
|
|
|
|
0%
|
|
|
|
no frequency information
|
|
|
|
not found on label
|
|
|
Labels
Labels were obtained from different sources and potentially contain different sets of side effects. If you click on the label name, a HTML version of the label will be shown with proteins, chemicals and side efffects highlighted using Reflect.
- DOLASETRON MESYLATE / ANZEMET INJECTION 20 MG/ML :
85 side effects
(Health Canada)
- dolasetron :
42 side effects
(FDA XML label)
- DOLASETRON MESYLATE / ANZEMET :
85 side effects
(Drugs@FDA)
- dolasetron :
87 side effects
(FDA XML label)
- dolasetron mesylate / Anzemet Tablets :
87 side effects
(FDA MedWatch)
- DOLASETRON MESYLATE / ANZEMET :
85 side effects
(Drugs@FDA)
- DOLASETRON MESYLATE / ANZEMET :
89 side effects
(Drugs@FDA)
|